Jason Willis

12PUBLICATIONS
65CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical infection agents (incl. prions)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 01, 2026
Clinical impact of prospective circulating tumour DNA testing for minimal residual disease in colorectal cancer: the INTERCEPT programme experience.

|Jul 16, 2025
Phase II Trial of TAS-102 in Colorectal Cancer Patients With Circulating Tumor DNA-Defined Minimal Residual Disease After Adjuvant Therapy: INTERCEPT-TT.

Andrew J Pellatt, Alisha Bent, Nicholas Hornstein

|Jun 13, 2024
Symptomatic pseudoprogression in metastatic colorectal cancer.

Kasen Hutchings, Ajlan Al Zaki, Nishin Bhadkamkar

|Feb 03, 2024
Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma.

Abdelrahman Yousef, Mahmoud Yousef, Saikat Chowdhury

|Dec 12, 2023
Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination.

Kristen Simmons, Jane V Thomas, Kaysia Ludford

|Aug 23, 2023
Impact of KRAS Mutations and Co-mutations on Clinical Outcomes in Pancreatic Ductal Adenocarcinoma.

Abdelrahman Yousef, Mahmoud Yousef, Saikat Chowdhury

Pageof 2

Frequent Collaborators

6 joint publications

John Paul Shen

5 joint publications

Scott Kopetz

5 joint publications

Kanwal Raghav

5 joint publications

Van Morris